Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran for Mitral Stenosis Atrial Fibrillation Trial
NCT04045093Phase 4Active, not recruiting
- Sponsor
- The University of Hong Kong
- Start
- Oct 2020
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran in Atrial fibrillation (AFib), mitral stenosis (MS), sponsored by The University of Hong Kong. Started Oct 2020; status: active, not recruiting.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)mitral stenosis (MS)
Beyond the preview
Go deeper on NCT04045093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04045093.